DalsnaFinance

Merck and Gilead discontinue lung cancer drug trial

Markets Investing.com By Investing.com 08 Jun 2026 20:37 1 min read
Merck and Gilead discontinue lung cancer drug trial

Merck and Gilead discontinue lung cancer drug trial

Merck and Gilead discontinue lung cancer drug trial

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.